Cancer Risk in Peutz–Jeghers Syndrome and LKB1/STK11 Mutations
Author Information
Author(s): Lim W, Hearle N, Shah B, Murday V, Hodgson S V, Lucassen A, Eccles D, Talbot I, Neale K, Lim A G, O'Donohue J, Donaldson A, Macdonald R C, Young I D, Robinson M H, Lee P W R, Stoodley B J, Tomlinson I, Alderson D, Holbrook A G, Vyas S, Swarbrick E T, Lewis A A M, Phillips R K S, Houlston R S
Primary Institution: Institute of Cancer Research
Hypothesis
What is the relationship between LKB1/STK11 mutations and cancer risk in Peutz–Jeghers syndrome?
Conclusion
The study found that LKB1/STK11 mutations are associated with a significantly increased risk of cancer in patients with Peutz–Jeghers syndrome.
Supporting Evidence
- 52% of patients with Peutz–Jeghers syndrome had detectable LKB1/STK11 mutations.
- The probability of developing cancer by age 65 years in all PJS patients was 37%.
- Carriers of LKB1/STK11 mutations had a 47% probability of developing cancer by age 65.
- Breast cancer risk in carriers was 29% by age 65.
Takeaway
Kids with a condition called Peutz–Jeghers syndrome have a higher chance of getting cancer, especially if they have certain gene changes.
Methodology
The study analyzed 33 families with Peutz–Jeghers syndrome, collecting clinical information and performing genetic testing for LKB1/STK11 mutations.
Potential Biases
There may be a risk of selection bias as patients were ascertained through specific medical professionals.
Limitations
Some mutations may have gone undetected, and the study's sample size is relatively small.
Participant Demographics
The study included 33 index patients with Peutz–Jeghers syndrome, with a mix of familial and sporadic cases.
Statistical Information
P-Value
0.03
Confidence Interval
95% CI: 33–69%
Statistical Significance
p=0.03
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website